Research and Education

Research

Research
Completed Projects

Discover the publishings from research projects completed in collaboration with academic partners and industrial partners from France or abroad.

Academic Partners
France

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness. Cancer Med. 

Long E, Ilie M, Bence C, Butori C, Selva E, Lalvée S, Bonnetaud C, Poissonnet G, Lacour JP, Bahadoran P, Brest P, Gilson E, Ballotti R, Hofman V, Hofman P. 

Project in collaboration with C3M – Inserm U1065, Nice; Robert Ballotti, Laurent Charvet

2016 Jun;5(6):1022-30.

A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib. J Invest Dermatol. 
Allegra M, Giacchero D, Segalen C, Dumaz N, Butori C, Hofman V, Hofman P, Lacour JP, Bertolotto C, Bahadoran P, Ballotti R. 

Project in collaboration with C3M – Inserm U1065, Nice; Robert Ballotti, Laurent Charvet

2014 May;134(5):1473-1476.

Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma. 
J Clin Oncol. Bahadoran P, Allegra M, Le Duff F, Long-Mira E, Hofman P, Giacchero D, Passeron T, Lacour JP, Ballotti R. 

Project in collaboration with:
3M – Inserm U1065, Nice; Robert Ballotti, Laurent Charvet

2013 Jul 1;31(19): e324-6.

Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res

Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Poudenx M, Sibon S, Kelhef S, Vénissac N, Jais JP, Mouroux J, Molina TJ, Hofman P.

Project in collaboration with: 
GRC-UPM 04 Theranoscan, Hôpital Tenon, Paris; Jacques Cadranel
INSERM U970, équipe 10, Hôpital Européen Georges Pompidou, Paris ; Eric Tartour 
Université Paris Descartes, UMR-S 1147, Paris ; Pierre Laurent-Puig
Institut Gustave Roussy, Villejuif ; Philippe Vielh, Pierre Fouret, Julien Adam

2011 Feb 15;17(4):827-35.
International

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients. Oncotarget

Ilie M, Szafer-Glusman E, Hofman V, Long-Mira E, Suttmann R, Darbonne W, Butori C, Lalvée S, Fayada J, Selva E, Yu W, Marquette CH, Shames DS, Punnoose E, Hofman P. 

Project in collaboration with: 
Genentech Inc. South San Francisco, USA; Edith Szafer-Glusman, Elizabeth Punnoose

2017 Apr 18;8(16):26112-26121.

PD-L1 expression in primary tumor and circulating tumor cells in patients with advanced non-small cell lung cancer. Annals of Oncology

Ilie M, Szafer-Glusman E, Hofman V, Long-Mira E, Lalvée S, Selva E, Marquette CH, Kowanetz M, Hedge P, Punnoose E, Hofman P. mdx636, 2018.

Project in collaboration with: 
Genentech Inc. South San Francisco, USA; Edith Szafer-Glusman, Elizabeth Punnoose

Oral presentation at the XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology, Koln 2016

mdx636, 2018.

Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms. PLoS One.

Ilie M, Khambata-Ford S, Copie-Bergman C, Huang L, Juco J, Hofman V, Hofman P. 

Project in collaboration with: 
Merck & Co., Inc., Kenilworth, USA; Shirin Khambata-Ford, Jonathan Juco
 

Posters at: 
– ASCO Annual Meeting 2017, Chicago, USA
– ESMO Congress 2017, Madrid, Spain
2017 Aug 10;12(8):e0183023

Posters:

  • Evaluation of CTCs in Clinical Samples: Enumeration, Biomarkers and Single Cell analysis. Gordon Research Conference “Rare Cells in Circulation”. South Hadley, USA. 2014.
    Szafer-Glusman E, Liu W, Suttman R, Do A, Sumiyoshi T, Darbonne W, Marquette CH, Ilie M, Hofman P, Tucker E, Marrinucci D, Mohan S, Pandita A, Prolux R, Ferraldeschi R, Attard G, deBono J, Punnoose E.

  • Expression of Met in Circulating Tumor Cells Correlates with Tumor Tissue in NSCLC Patients. United States and Canadian Academy of Pathology Congress. Boston, USA. 2015.
    Ilie M, Szafer-Glusman E, Hofman V, Long-Mira E, Butori C, Lalvée S, Fayada J, Selva E, Marquette CH, Punnoose E, Hofman P.

  • MET expression in circulating tumor cells (CTCs) isolated on the ISET platform correlates with MET expression in matched tumor tissue in advanced NSCLC patients. AACR Annual Meeting 2015. Philadelphia, USA.
    Ilie M, Szafer-Glusman E, Hofman V, Long-Mira E, Suttman R, Darbonne W, Butori C, Lalvée S, Fayada J, Selva E, Marquette CH, Shames DS, Punnoose E, Hofman P. 
(…)1
Industrial Partners
Luciana Batista, Nicolas Brandone, Stéphane Garcia, Emmanuel Prestat, Elodie Malifarge, Anne Legrand, Caroline Laugé, Yanis Boumber, Essel Dulaimi, Philippe Tanière, Paul Hofman, Marius Ilié, Julien Adam, Jerome Galon, Catherine Gerbon, Jacques Fieschi.

Project in collaboration with: 
– HalioDx, Marseille, France; Fabienne Hermitte

(…)2
Paul Hofman, Mélanie Beaulande, Saima Ben Hadj, Gilles Erb, Jean-François Pomerol, Sandra Lassalle, Catherine Butori, Elodie Long, Kevin Washetine, Olivier Guerin, Joel Guigay, Jerome Mouroux, Sylvie Leroy, Charles Hugo Marquette, Veronique Hofman, Marius Ilie.

Project in collaboration with: 

– Roche Diagnostics RTD, Meylan ; Gilles Erb
(…)3
Publication : Ilie M, Nunes M, Blot L, Hofman V, Long-Mira E, Butori C, Selva E, Merino-Trigo A, Vénissac N, Mouroux J, Vrignaud P, Hofman P. 

Project in collaboration with: 

– Imagene, Genopole Campus 1; Marthe Colotte
– Sanofi-Aventis, Paris ; Patricia Vrignaud
2015 Feb;4(2):201-11.
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators. Eur J Cancer.
Rakha E, Pajares MJ, Ilie M, Pio R, Echeveste J, Hughes E, Soomro I, Long E, Idoate MA, Wagner S, Lanchbury JS, Baldwin DR, Hofman P, Montuenga LM. 

Project in collaboration with:
– Agilent Technologies Inc. Santa Clara, USA; Nina Green

– Trans-Hit Biomarkers, Laval, Canada; Pascal Puchois, Robert Hewitt
– QIAGEN GmbH, Hilden, Germany
– Debiopharm SA, Lausanne, Switzerland; Stefania Rigotti
– Biotheranostic, San Diego, USA; Mark Erlander
– Myriad Genetics, Salt Lake City, USA; Susanne Wagner
2015 Sep;51(14):1897-903.
For more information, visit the following topics:
Our partners
Scientific publishing
Education
Cookies
Nous utilisons des cookies. Vous pouvez configurer ou refuser les cookies dans votre navigateur. Vous pouvez aussi accepter tous les cookies en cliquant sur le bouton « Accepter tous les cookies ». Pour plus d’informations, vous pouvez consulter notre Politique de confidentialité et des cookies.